Interestingly, recent studies have shown promoter translocations to be common drivers of ABCB1 expression in recurrent, chemotherapy-treated high-grade serous ovarian (HGSC) and breast cancer [2, 3]. Here, ABCB1 is linked to breast carcinoma.